EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Improved Biopharmaceutical Performance of Coenzyme Q10 Through Solid Lipid Nanoparticles for Enhanced Brain Delivery

Shimul Halder iD, Faria Nasrin, Manik Chandra Shill iD, Madhabi Lata Shuma iD, Md Zakir Sultan iD, Md Selim Reza iD

Scientifica · 2025-01 · 2025 (1)

DOI: 10.1155/sci5/9034181 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Scientifica, online erschienen am 16.06.2025. Verfasst von Shimul Halder und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Dhaka, Dhaka 1000, Bangladesh. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coenzyme Q10 (CoQ) is a powerful antioxidant with neuroprotective characteristics; nevertheless, its clinical use is constrained by inadequate solubility, diminished bioavailability, and limited blood–brain barrier (BBB) penetration. Solid lipid nanoparticles (SLNs) offer a promising approach to improve the biopharmaceutical characteristics and targeted delivery of CoQ to the brain. This study focuses on the strategic formulation and optimization of SLN‐CoQ to improve solubility, oral absorption, and BBB permeability. The SLNs with drug loading of 2.5% (w/w) were prepared using a solvent injection technique and physicochemically characterized employing encapsulation efficiency, drug loading, particle size, zeta potential, surface morphology, crystallinity, in vitro drug release behavior, and mucus penetrating behavior. Pharmacokinetic studies were conducted in rats (100 mg‐CoQ/kg, p.o.) after oral administration to elucidate the possible enhancement in the oral absorption of CoQ. The SLN‐CoQ (F2) exhibited favorable physicochemical characteristics, including optimal particle size (91.6 ± 8.2 nm), zeta potential (−41.7 ± 1.03 mV), high encapsulation efficiency (85.2 ± 5.0), distinct surface morphology, reduced crystallinity, enhanced drug release, and better mucus penetration than crystalline CoQ. In the dissolution test, SLN‐CoQ demonstrated a significant enhancement in the dissolution profile of CoQ as exhibited by an 83.6‐fold higher dissolved amount of CoQ in 120 min in water in the F2 formulation ratio. Moreover, in the artificial mucus test, a 42‐fold increase in mucus permeation was observed for the F2 formulation compared to the crystalline drug. Orally administered CoQ exhibited a higher systemic exposure of CoQ (3.6‐fold higher) in SLLN‐CoQ compared to crystalline CoQ, with prolonged circulation time and improved tissue distribution (3‐fold higher) in rats. The findings suggest that SLN‐CoQ offers a feasible nanotechnological method for enhanced drug transport to the brain, potentially aiding therapeutic approaches for neurodegenerative diseases, including Parkinson’s and Alzheimer’s.

Schlagwörter

Stichwörter der Autor:innen

BBBcoenzyme Q10solid lipid nanoparticlessolvent injectionsystemic exposure

Autor:innen und Institutionen

  • Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Dhaka, Dhaka 1000, Bangladesh.
  • School of Pharmacy, Brac University, KHA 224, Progati Sarani, Merul Badda, Dhaka 1212, Bangladesh.
  • Department of Pharmaceutical Sciences, North South University, Dhaka 1229, Bangladesh.
  • Department of Pharmacy, School of Pharmacy and Public Health, Independent University Bangladesh, Dhaka 1229, Bangladesh.
  • Centre for Advanced Research in Sciences, University of Dhaka, Dhaka 1000, Bangladesh.

ORCID-Profile: Shimul Halder, Manik Chandra Shill, Madhabi Lata Shuma, Md Zakir Sultan, Md Selim Reza

Zitieren

APA

Halder, S., Nasrin, F., Chandra Shill, M., Shuma, M. L., Sultan, M. Z., & Reza, M. S. (2025). Improved Biopharmaceutical Performance of Coenzyme Q10 Through Solid Lipid Nanoparticles for Enhanced Brain Delivery. Scientifica, 2025(1). https://doi.org/10.1155/sci5/9034181

Vancouver

Halder S, Nasrin F, Chandra Shill M, Shuma ML, Sultan MZ, Reza MS. Improved Biopharmaceutical Performance of Coenzyme Q10 Through Solid Lipid Nanoparticles for Enhanced Brain Delivery. Scientifica. 2025;2025(1). doi:10.1155/sci5/9034181

BibTeX
@article{Halder2025,
  author = {Halder, Shimul and Nasrin, Faria and Chandra Shill, Manik and Shuma, Madhabi Lata and Sultan, Md Zakir and Reza, Md Selim},
  title = {Improved Biopharmaceutical Performance of Coenzyme Q10 Through Solid Lipid Nanoparticles for Enhanced Brain Delivery},
  journal = {Scientifica},
  year = {2025},
  volume = {2025},
  number = {1},
  doi = {10.1155/sci5/9034181}
}
Kostenlos starten →